TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ANALGESICS MARKET, BY DRUG CLASS
6.1. Overview
6.2. Opioids
6.3. NSAIDs
6.4. Local Anesthetics
6.5. Acetaminophen
7. GLOBAL ANALGESICS MARKET, BY INDICATION
7.1. Overview
7.2. Surgical Pain
7.3. Cancer Pain
7.4. Neuropathic Pain
7.5. Others
8. GLOBAL ANALGESICS MARKET, BY TYPE
8.1. Overview
8.2. Prescription
8.3. OTC
9. GLOBAL ANALGESICS MARKET, BY APPLICATION
9.1. Overview
9.2. Internal Analgesics
9.3. External Analgesics
10. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
10.1. Overview
10.2. Oral
10.3. Parenteral
10.4. Transdermal
10.5. Others
11. GLOBAL ANALGESICS MARKET, BY DISTRIBUTION CHANNEL
11.1. Overview
11.2. Hospital pharmacies
11.3. Retail pharmacies
11.4. Drug Stores
11.5. Online pharmacies
12. GLOBAL ANALGESICS MARKET, BY REGION
12.1. Overview
12.1. North America
12.1.1. US
12.1.2. Canada
12.2. Europe
12.2.1. Germany
12.2.2. France
12.2.3. UK
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Asia-Pacific
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. South Korea
12.3.5. Australia
12.3.6. Rest of Asia-Pacific
12.4. Rest of the World
12.4.1. Middle East
12.4.2. Africa
12.4.3. Latin America
13. COMPETITIVE LANDSCAPE
13.1. Overview
13.2. Competitive Analysis
13.3. Market Share Analysis
13.4. Major Growth Strategy in the Global Analgesics Market,
13.5. Competitive Benchmarking
13.6. Leading Players in Terms of Number of Developments in the Global Analgesics Market,
13.7. Key developments and Growth Strategies
13.7.1. New Product Launch/Service Deployment
13.7.2. Merger & Acquisitions
13.7.3. Joint Ventures
13.8. Major Players Financial Matrix
13.8.1. Sales & Operating Income, 2022
13.8.2. Major Players R&D Expenditure. 2022
14. COMPANY PROFILES
14.1. Abbott
14.1.1. Company Overview
14.1.2. Financial Overview
14.1.3. Products Offered
14.1.4. Key Developments
14.1.5. SWOT Analysis
14.1.6. Key Strategies
14.2. Pfizer Inc.
14.2.1. Company Overview
14.2.2. Financial Overview
14.2.3. Products Offered
14.2.4. Key Developments
14.2.5. SWOT Analysis
14.2.6. Key Strategies
14.3. Eli Lilly & Company
14.3.1. Company Overview
14.3.2. Financial Overview
14.3.3. Products Offered
14.3.4. Key Developments
14.3.5. SWOT Analysis
14.3.6. Key Strategies
14.4. GSK plc.
14.4.1. Company Overview
14.4.2. Financial Overview
14.4.3. Products Offered
14.4.4. Key Developments
14.4.5. SWOT Analysis
14.4.6. Key Strategies
14.5. F. Hoffmann-La Roche AG
14.5.1. Company Overview
14.5.2. Financial Overview
14.5.3. Products Offered
14.5.4. Key Developments
14.5.5. SWOT Analysis
14.5.6. Key Strategies
14.6. Bausch Health Companies Inc.
14.6.1. Company Overview
14.6.2. Financial Overview
14.6.3. Products Offered
14.6.4. Key Developments
14.6.5. SWOT Analysis
14.6.6. Key Strategies
14.7. Merck & Co. Inc.
14.7.1. Company Overview
14.7.2. Financial Overview
14.7.3. Products Offered
14.7.4. Key Developments
14.7.5. SWOT Analysis
14.7.6. Key Strategies
14.8. AbbVie Inc.
14.8.1. Company Overview
14.8.2. Financial Overview
14.8.3. Products Offered
14.8.4. Key Developments
14.8.5. SWOT Analysis
14.8.6. Key Strategies
14.9. Novartis AG
14.9.1. Company Overview
14.9.2. Financial Overview
14.9.3. Products Offered
14.9.4. Key Developments
14.9.5. SWOT Analysis
14.9.6. Key Strategies
14.10. Johnson & Johnson Private Limited
14.10.1. Company Overview
14.10.2. Financial Overview
14.10.3. Products Offered
14.10.4. Key Developments
14.10.5. SWOT Analysis
14.10.6. Key Strategies
15. APPENDIX
15.1. References
15.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANALGESICS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ANALGESICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 8 GLOBAL ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 NORTH AMERICA ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 NORTH AMERICA ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 14 NORTH AMERICA ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 15 US: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 16 US: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 17 US: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 US: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 US: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 20 US: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 21 CANADA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 22 CANADA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 23 CANADA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 24 CANADA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 CANADA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 26 CANADA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 EUROPE: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 EUROPE: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 6 EUROPE: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 GERMANY: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 8 GERMANY: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 9 GERMANY: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 GERMANY: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 GERMANY: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 12 GERMANY: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 13 FRANCE: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 14 FRANCE: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 15 FRANCE: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 FRANCE: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 FRANCE: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 18 FRANCE: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 19 ITALY: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 20 ITALY: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 21 ITALY: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 22 ITALY: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 ITALY: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 24 ITALY: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 25 SPAIN: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 26 SPAIN: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 27 SPAIN: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 28 SPAIN: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 SPAIN: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 30 SPAIN: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 31 UK: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 32 UK: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 33 UK: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 34 UK: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 UK: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 36 UK: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 38 REST OF EUROPE: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 39 REST OF EUROPE: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 40 REST OF EUROPE: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 REST OF EUROPE: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF EUROPE: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 43 ASIA-PACIFIC: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 44 ASIA-PACIFIC: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 45 ASIA-PACIFIC: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 46 ASIA-PACIFIC: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 49 JAPAN: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 50 JAPAN: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 51 JAPAN: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 52 JAPAN: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 JAPAN: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 54 JAPAN: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 55 CHINA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 56 CHINA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 57 CHINA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 58 CHINA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 CHINA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 60 CHINA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 61 INDIA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 62 INDIA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 63 INDIA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 64 INDIA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 65 INDIA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 66 INDIA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 70 AUSTRALIA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 71 AUSTRALIA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 72 AUSTRALIA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 74 SOUTH KOREA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 75 SOUTH KOREA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 76 SOUTH KOREA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 77 SOUTH KOREA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 78 SOUTH KOREA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 79 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 80 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 81 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 82 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 83 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 84 REST OF ASIA-PACIFIC: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 85 REST OF THE WORLD: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 86 REST OF THE WORLD: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 87 REST OF THE WORLD: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 88 REST OF THE WORLD: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 89 REST OF THE WORLD: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 90 REST OF THE WORLD: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 91 MIDDLE EAST: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 92 MIDDLE EAST: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 93 MIDDLE EAST: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 94 MIDDLE EAST: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 95 MIDDLE EAST: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 96 MIDDLE EAST: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 97 AFRICA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 98 AFRICA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 99 AFRICA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 100 AFRICA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 101 AFRICA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 102 AFRICA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 103 LATIN AMERICA: ANALGESICS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 104 LATIN AMERICA: ANALGESICS MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 105 LATIN AMERICA: ANALGESICS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 106 LATIN AMERICA: ANALGESICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 107 LATIN AMERICA: ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: ANALGESICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANALGESICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANALGESICS MARKET
FIGURE 4 GLOBAL ANALGESICS MARKET, SHARE (%), BY DRUG CLASS, 2022
FIGURE 5 GLOBAL ANALGESICS MARKET, SHARE (%), BY INDICATION, 2022
FIGURE 6 GLOBAL ANALGESICS MARKET, SHARE (%), BY TYPE, 2022
FIGURE 7 GLOBAL ANALGESICS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 8 GLOBAL ANALGESICS MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022
FIGURE 9 GLOBAL ANALGESICS MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 10 GLOBAL ANALGESICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 NORTH AMERICA: ANALGESICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 EUROPE: ANALGESICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 ASIA-PACIFIC: ANALGESICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 14 REST OF THE WORLD: ANALGESICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 15 GLOBAL ANALGESICS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 16 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ABBOTT: SWOT ANALYSIS
FIGURE 18 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 PFIZER INC.: SWOT ANALYSIS
FIGURE 20 ELI LILLY & COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ELI LILLY & COMPANY: SWOT ANALYSIS
FIGURE 22 GSK PLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 GSK PLC.: SWOT ANALYSIS
FIGURE 24 F. HOFFMANN-LA ROCHE AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 F. HOFFMANN-LA ROCHE AG: SWOT ANALYSIS
FIGURE 26 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS
FIGURE 28 MERCK & CO. INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 MERCK & CO. INC.: SWOT ANALYSIS
FIGURE 30 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ABBVIE INC.: SWOT ANALYSIS
FIGURE 32 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 NOVARTIS AG: SWOT ANALYSIS
FIGURE 34 JOHNSON & JOHNSON PRIVATE LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 JOHNSON & JOHNSON PRIVATE LIMITED: SWOT ANALYSIS